Engineers develop a way to mass manufacture nanoparticles that deliver cancer drugs directly to tumors

MIT researchers have developed a new manufacturing technique for polymer-coated nanoparticles that could improve cancer treatment. The method uses a microfluidic mixing device to create larger quantities of nanoparticles faster, making it more suitable for clinical trials and patient use. This advancement builds on previous work showing these nanoparticles can effectively combat cancer in mice, particularly ovarian cancer. The new process streamlines production, integrates FDA-compliant practices, and could enable faster development of promising cancer therapies using targeted nanoparticles.